![Lonnel Coats](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lonnel Coats
Direktor/Vorstandsmitglied bei
RELAY THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Lonnel Coats gründete die Eisai Corp. of North America. Derzeit ist Herr Coats President, Chief Executive Officer & Director bei Lexicon Pharmaceuticals, Inc. Herr Coats ist auch im Vorstand von Blueprint Medicines Corp. In der Vergangenheit bekleidete Herr Coats die Position des Executive Vice President bei Eisai Co., Ltd. President & Chief Executive Officer von Eisai, Inc. und President & Chief Operating Officer für Eisai Corp. of North America (beides sind Tochtergesellschaften von Eisai Co., Ltd.). Lonnel Coats erwarb einen Bachelor-Abschluss an der Oakland University (Michigan).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Lonnel Coats
| Unternehmen | Position | Beginn |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.11.2025 |
Ehemalige bekannte Positionen von Lonnel Coats
| Unternehmen | Position | Ende |
|---|---|---|
| VERE THER | Direktor/Vorstandsmitglied | 25.07.2025 |
| BLUEPRINT MEDICINES CORPORATION | Direktor/Vorstandsmitglied | 17.07.2025 |
| LEXICON PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 07.07.2024 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Vorstandsvorsitzender | 01.01.2014 |
Eisai Corp. of North America
 Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.01.2014 |
Ausbildung von Lonnel Coats
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology Develops. manufactures & markets pharmaceutical and medical products for therapeutic markets | Health Technology |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Eisai Co., Ltd.
 Eisai Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacturing and sales of prescription and over-the-counter drugs | Commercial Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Oakland University (Michigan)
 Oakland University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eisai Corp. of North America
Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
